Dr. Shane Anthony Bobart, MD

Dr. Bobart practices at Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic.

Dr. Bobart's NPI, 1225456882, was assigned on April 1, 2014. Dr. Bobart graduated from St. George's University School of Medicine in 2014. Dr. Bobart holds Texas license U3482.

Dr. Bobart's primary practice is Mayo Clinic Hospital, at 4500 San Pablo Rd, Jacksonville, FL 32224 in Duval County. The practice phone is (904) 953-2000.

Dr. Bobart's primary practice is Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic. The medical group on file is Mayo Clinic Jacksonville. Dmand AI also links Dr. Bobart to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bobart practices, 2 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Bobart's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Bobart is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Bobart's licenses on file in 4 states: Texas, Florida, Minnesota and Ohio.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances and kidney disease among the conditions Dr. Bobart treats.

CMS data shows 483 Medicare services from Dr. Bobart across 7 procedure codes in 2024, for 113 Medicare patients. Medicare paid $34,995 for them.

CMS counts 113 Medicare patients who saw Dr. Bobart in 2024. The largest group is 65 to 74, with 44 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 14% are also on Medicaid. Their average risk score is 3.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bobart's median patient age at 60, with 43% women.

In 2024, Dr. Bobart wrote 202 Medicare Part D claims for 53 patients. 81% of them were for generic drugs. CMS names the drug for 88 of them, across 5 drugs with 11 or more claims each, at $22,201 in total drug cost. In 2023, CMS named 333 claims across 13 drugs.

Dr. Bobart accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bobart as offering telehealth.

Dmand AI links 26 papers to Dr. Bobart, published from 2017 to 2025. 2020 was the busiest year, with 5. The most frequent topics are Biopsy, Glomerulonephritis, Membranous and Kidney. Dr. Bobart has published most often in Clin J Am Soc Nephrol. Dr. Bobart's most frequent co-authors are Fernando C. Fervenza, MD, Surafel Kebede Gebreselassie, MD and Gilda Melissa Portalatin, MD.

CMS Open Payments shows 20 general payments to Dr. Bobart from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 89% of the total. Sunovion Pharmaceuticals Inc. paid the most, $206.

Dmand AI lists 1 award for Dr. Bobart.

Dr. Bobart graduated from St. George's University School of Medicine in 2014. Dr. Bobart is a member of ASN.

Dr. Bobart is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.